For ERBB2, several studies indicated that ERBB2+ MBC patients have EMT-like CTC and that ERBB2 seems to be selectively expressed in cancer stem cells of initially ER+ and ERBB2-negative luminal BC [10, 55]. This evidence concerns the gene ERBB2 and cancer.